Furthermore, the combined model II (RBP4/HOMA-IR/diabetes duration/Hs-CRP/HbA1c) improved the ability of every single marker and model I to diagnose DR (AUC of the combined model 0.87; 95% CI: 0.80–0.92; P<0.05). Here, CRP is linked to diabetes mellitus.